140 related articles for article (PubMed ID: 31775072)
1. Cellular uptake of protic ruthenium complexes is influenced by pH dependent passive diffusion and energy dependent efflux.
Park S; Gray JL; Altman SD; Hairston AR; Beswick BT; Kim Y; Papish ET
J Inorg Biochem; 2020 Feb; 203():110922. PubMed ID: 31775072
[TBL] [Abstract][Full Text] [Related]
2. Ruthenium Complexes are pH-Activated Metallo Prodrugs (pHAMPs) with Light-Triggered Selective Toxicity Toward Cancer Cells.
Qu F; Park S; Martinez K; Gray JL; Thowfeik FS; Lundeen JA; Kuhn AE; Charboneau DJ; Gerlach DL; Lockart MM; Law JA; Jernigan KL; Chambers N; Zeller M; Piro NA; Kassel WS; Schmehl RH; Paul JJ; Merino EJ; Kim Y; Papish ET
Inorg Chem; 2017 Jul; 56(13):7519-7532. PubMed ID: 28636344
[TBL] [Abstract][Full Text] [Related]
3. Singlet Oxygen Formation vs Photodissociation for Light-Responsive Protic Ruthenium Anticancer Compounds: The Oxygenated Substituent Determines Which Pathway Dominates.
Qu F; Lamb RW; Cameron CG; Park S; Oladipupo O; Gray JL; Xu Y; Cole HD; Bonizzoni M; Kim Y; McFarland SA; Webster CE; Papish ET
Inorg Chem; 2021 Feb; 60(4):2138-2148. PubMed ID: 33534562
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, characterization and biological evaluation of novel Ru(II)-arene complexes containing intercalating ligands.
Nikolić S; Rangasamy L; Gligorijević N; Aranđelović S; Radulović S; Gasser G; Grgurić-Šipka S
J Inorg Biochem; 2016 Jul; 160():156-65. PubMed ID: 26818702
[TBL] [Abstract][Full Text] [Related]
5. Ruthenium Complexes with Protic Ligands: Influence of the Position of OH Groups and π Expansion on Luminescence and Photocytotoxicity.
Oladipupo OE; Prescott MC; Blevins ER; Gray JL; Cameron CG; Qu F; Ward NA; Pierce AL; Collinson ER; Hall JF; Park S; Kim Y; McFarland SA; Fedin I; Papish ET
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36983054
[TBL] [Abstract][Full Text] [Related]
6. Ruthenium dihydroxybipyridine complexes are tumor activated prodrugs due to low pH and blue light induced ligand release.
Hufziger KT; Thowfeik FS; Charboneau DJ; Nieto I; Dougherty WG; Kassel WS; Dudley TJ; Merino EJ; Papish ET; Paul JJ
J Inorg Biochem; 2014 Jan; 130():103-11. PubMed ID: 24184694
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, characterization, and anticancer activity of ruthenium(II)-β-carboline complex.
Chen Y; Qin MY; Wu JH; Wang L; Chao H; Ji LN; Xu AL
Eur J Med Chem; 2013; 70():120-9. PubMed ID: 24141202
[TBL] [Abstract][Full Text] [Related]
8. Carbonyl-heterobimetallic Ru(II)/Fe(II)-complexes containing polypyridyl ligands: Synthesis, characterization, cellular viability assays and interactions with biomolecules.
Dávila-Rodríguez MJ; Barolli JP; de Oliveira KM; Colina-Vegas L; da Silva Miranda F; Castellano EE; Von Poelhsitz G; Batista AA
Arch Biochem Biophys; 2018 Dec; 660():156-167. PubMed ID: 30389443
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, spectroscopic characterization, photochemical and photophysical properties and biological activities of ruthenium complexes with mono- and bi-dentate histamine ligand.
Cardoso CR; de Aguiar I; Camilo MR; Lima MV; Ito AS; Baptista MS; Pavani C; Venâncio T; Carlos RM
Dalton Trans; 2012 Jun; 41(22):6726-34. PubMed ID: 22539182
[TBL] [Abstract][Full Text] [Related]
10. Anticancer activity of ruthenium(II) arene complexes bearing 1,2,3,4-tetrahydroisoquinoline amino alcohol ligands.
Chelopo MP; Pawar SA; Sokhela MK; Govender T; Kruger HG; Maguire GE
Eur J Med Chem; 2013 Aug; 66():407-14. PubMed ID: 23827181
[TBL] [Abstract][Full Text] [Related]
11. Light-responsive and Protic Ruthenium Compounds Bearing Bathophenanthroline and Dihydroxybipyridine Ligands Achieve Nanomolar Toxicity towards Breast Cancer Cells.
Oladipupo OE; Brown SR; Lamb RW; Gray JL; Cameron CG; DeRegnaucourt AR; Ward NA; Hall JF; Xu Y; Petersen CM; Qu F; Shrestha AB; Thompson MK; Bonizzoni M; Webster CE; McFarland SA; Kim Y; Papish ET
Photochem Photobiol; 2022 Jan; 98(1):102-116. PubMed ID: 34411308
[TBL] [Abstract][Full Text] [Related]
12. Amberlite IR-120 (H) mediated "on water" synthesis of fluorescent Ruthenium(II)-arene 8-hydroxyquinoline complexes for cancer therapy and live cell imaging.
Mondal A; De S; Maiti S; Sarkar B; Sk AK; Jacob R; Moorthy A; Paira P
J Photochem Photobiol B; 2018 Jan; 178():380-394. PubMed ID: 29195215
[TBL] [Abstract][Full Text] [Related]
13. Ruthenium(II) polypyridyl complexes: synthesis and studies of DNA binding, photocleavage, cytotoxicity, apoptosis, cellular uptake, and antioxidant activity.
Liu YJ; Liang ZH; Li ZZ; Yao JH; Huang HL
DNA Cell Biol; 2011 Oct; 30(10):829-38. PubMed ID: 21395447
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxicity, apoptosis, cellular uptake, cell cycle arrest, photocleavage, and antioxidant activity of 1, 10-phenanthroline ruthenium(II) complexes.
Liu YJ; Li ZZ; Liang ZH; Yao JH; Huang HL
DNA Cell Biol; 2011 Oct; 30(10):839-48. PubMed ID: 21568758
[TBL] [Abstract][Full Text] [Related]
15. Organometallic ruthenium(II)-arene complexes with triphenylphosphine amino acid bioconjugates: Synthesis, characterization and biological properties.
Pernar M; Kokan Z; Kralj J; Glasovac Z; Tumir LM; Piantanida I; Eljuga D; Turel I; Brozovic A; Kirin SI
Bioorg Chem; 2019 Jun; 87():432-446. PubMed ID: 30925428
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, characterization, cellular uptake and apoptosis-inducing properties of two highly cytotoxic cyclometalated ruthenium(II) β-carboline complexes.
Chen J; Peng F; Zhang Y; Li B; She J; Jie X; Zou Z; Chen M; Chen L
Eur J Med Chem; 2017 Nov; 140():104-117. PubMed ID: 28923379
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of iridium and ruthenium complexes with (N,N), (N,O) and (O,O) coordinating bidentate ligands as potential anti-cancer agents.
Lucas SJ; Lord RM; Wilson RL; Phillips RM; Sridharan V; McGowan PC
Dalton Trans; 2012 Dec; 41(45):13800-2. PubMed ID: 23015068
[TBL] [Abstract][Full Text] [Related]
18. First polymer "ruthenium-cyclopentadienyl" complex as potential anticancer agent.
Valente A; Garcia MH; Marques F; Miao Y; Rousseau C; Zinck P
J Inorg Biochem; 2013 Oct; 127():79-81. PubMed ID: 23896008
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, interaction with DNA, cytotoxicity, cell cycle arrest and apoptotic inducing properties of ruthenium(II) molecular "light switch" complexes.
Shobha Devi C; Anil Kumar D; Singh SS; Gabra N; Deepika N; Kumar YP; Satyanarayana S
Eur J Med Chem; 2013 Jun; 64():410-21. PubMed ID: 23665797
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of novel anticancer ruthenium-arene pyridinylmethylene scaffolds via three-component reaction.
Jadhav GR; Sinha S; Chhabra M; Paira P
Bioorg Med Chem Lett; 2016 Jun; 26(11):2695-700. PubMed ID: 27090558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
